

MOLECL
Detecting Small Changes. Delivering Big Impact — One Molecule at a Time.

Our Technology
based on solid-state nanopore biosensing
Built on proprietary solid-state nanopore biosensing, MOLECL enables rapid single-molecule characterization for diagnostics and biopharma applications.
We detect critical molecular fingerprints, including post-translational modifications and structural variants, that conventional assays often miss. Our platform supports applications ranging from biomarker discovery and early cancer diagnostics to biologics characterization and manufacturing quality control.
Our mission is to make molecular analysis faster, more precise, and more accessible through a compact, scalable platform combining advanced nanofluidics, disposable flow cells, and AI-driven signal analysis.
With a workflow as simple as a coffee capsule machine, users select the appropriate nanopore cartridge and software package for their application and obtain actionable results within minutes.

Applications
Genomics
-
QC and structural profiling for short- and long-read sequencing workflows
-
Advanced characterization of complex nucleic acids and ultra-long DNA
Biologics
-
Full-stack characterization of antibodies and biologic therapeutics
-
Stability, aggregation, and structural integrity analysis
Proteomics
-
Single-molecule protein and biomarker characterization
-
PTM and molecular heterogeneity analysis
the Team
We’re a team of 5!
Curious to learn more or interested in joining us?
Reach out, and we’ll get back to you! 😉
Supported by





Open positions
We're all set for now, but we're always looking for bright minds!
We are very happy to hear from you!




